Logo image of 1C3.MI

C3.AI INC-A (1C3.MI) Stock Fundamental Analysis

Europe - BIT:1C3 - US12468P1049 - Common Stock

13.808 EUR
-0.92 (-6.22%)
Last: 9/4/2025, 7:00:00 PM
Fundamental Rating

4

1C3 gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Software industry. 1C3 has a great financial health rating, but its profitability evaluates not so good. 1C3 is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

1C3 had negative earnings in the past year.
In the past year 1C3 has reported a negative cash flow from operations.
In the past 5 years 1C3 always reported negative net income.
1C3 had a negative operating cash flow in each of the past 5 years.
1C3.MI Yearly Net Income VS EBIT VS OCF VS FCF1C3.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -100M -200M -300M

1.2 Ratios

1C3 has a worse Return On Assets (-35.37%) than 86.14% of its industry peers.
The Return On Equity of 1C3 (-42.89%) is worse than 76.24% of its industry peers.
Industry RankSector Rank
ROA -35.37%
ROE -42.89%
ROIC N/A
ROA(3y)-26.48%
ROA(5y)-20.1%
ROE(3y)-31.79%
ROE(5y)-24.01%
ROIC(3y)N/A
ROIC(5y)N/A
1C3.MI Yearly ROA, ROE, ROIC1C3.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30

1.3 Margins

1C3 has a worse Gross Margin (56.47%) than 65.35% of its industry peers.
1C3's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for 1C3 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.75%
GM growth 5Y-4.23%
1C3.MI Yearly Profit, Operating, Gross Margins1C3.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

8

2. Health

2.1 Basic Checks

1C3 does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 1C3 has been increased compared to 1 year ago.
Compared to 5 years ago, 1C3 has more shares outstanding
1C3 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
1C3.MI Yearly Shares Outstanding1C3.MI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
1C3.MI Yearly Total Debt VS Total Assets1C3.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 5.69 indicates that 1C3 is not in any danger for bankruptcy at the moment.
The Altman-Z score of 1C3 (5.69) is better than 72.28% of its industry peers.
There is no outstanding debt for 1C3. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.69
ROIC/WACCN/A
WACC11.22%
1C3.MI Yearly LT Debt VS Equity VS FCF1C3.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

1C3 has a Current Ratio of 7.65. This indicates that 1C3 is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 7.65, 1C3 belongs to the top of the industry, outperforming 92.08% of the companies in the same industry.
A Quick Ratio of 7.65 indicates that 1C3 has no problem at all paying its short term obligations.
1C3's Quick ratio of 7.65 is amongst the best of the industry. 1C3 outperforms 92.08% of its industry peers.
Industry RankSector Rank
Current Ratio 7.65
Quick Ratio 7.65
1C3.MI Yearly Current Assets VS Current Liabilites1C3.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

6

3. Growth

3.1 Past

The earnings per share for 1C3 have decreased strongly by -69.05% in the last year.
Looking at the last year, 1C3 shows a quite strong growth in Revenue. The Revenue has grown by 14.34% in the last year.
1C3 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.95% yearly.
EPS 1Y (TTM)-69.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-640%
Revenue 1Y (TTM)14.34%
Revenue growth 3Y15.45%
Revenue growth 5Y19.95%
Sales Q2Q%-19.44%

3.2 Future

Based on estimates for the next years, 1C3 will show a very strong growth in Earnings Per Share. The EPS will grow by 25.04% on average per year.
Based on estimates for the next years, 1C3 will show a very strong growth in Revenue. The Revenue will grow by 34.07% on average per year.
EPS Next Y-51.94%
EPS Next 2Y4.49%
EPS Next 3Y29.42%
EPS Next 5Y25.04%
Revenue Next Year10.06%
Revenue Next 2Y12.92%
Revenue Next 3Y16.51%
Revenue Next 5Y34.07%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1C3.MI Yearly Revenue VS Estimates1C3.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B 4B
1C3.MI Yearly EPS VS Estimates1C3.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for 1C3. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for 1C3. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
1C3.MI Price Earnings VS Forward Price Earnings1C3.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1C3.MI Per share data1C3.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

A more expensive valuation may be justified as 1C3's earnings are expected to grow with 29.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.49%
EPS Next 3Y29.42%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for 1C3!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

C3.AI INC-A

BIT:1C3 (9/4/2025, 7:00:00 PM)

13.808

-0.92 (-6.22%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-03 2025-09-03/amc
Earnings (Next)12-08 2025-12-08/amc
Inst Owners52.13%
Inst Owner ChangeN/A
Ins Owners8.26%
Ins Owner ChangeN/A
Market Cap1.90B
Analysts50
Price Target20.35 (47.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-29.66%
Min EPS beat(2)-82.01%
Max EPS beat(2)22.69%
EPS beat(4)3
Avg EPS beat(4)14.53%
Min EPS beat(4)-82.01%
Max EPS beat(4)64.04%
EPS beat(8)7
Avg EPS beat(8)34.07%
EPS beat(12)11
Avg EPS beat(12)37.76%
EPS beat(16)15
Avg EPS beat(16)39.37%
Revenue beat(2)0
Avg Revenue beat(2)-14.95%
Min Revenue beat(2)-27.87%
Max Revenue beat(2)-2.02%
Revenue beat(4)1
Avg Revenue beat(4)-7.88%
Min Revenue beat(4)-27.87%
Max Revenue beat(4)0.62%
Revenue beat(8)1
Avg Revenue beat(8)-4.86%
Revenue beat(12)2
Avg Revenue beat(12)-3.49%
Revenue beat(16)3
Avg Revenue beat(16)-2.94%
PT rev (1m)-21.14%
PT rev (3m)-24.45%
EPS NQ rev (1m)-51.16%
EPS NQ rev (3m)-28.66%
EPS NY rev (1m)-57.49%
EPS NY rev (3m)-35.02%
Revenue NQ rev (1m)-10.43%
Revenue NQ rev (3m)-11.7%
Revenue NY rev (1m)-8.18%
Revenue NY rev (3m)-9.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.96
P/FCF N/A
P/OCF N/A
P/B 2.78
P/tB 2.78
EV/EBITDA N/A
EPS(TTM)-0.61
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-0.53
FCFYN/A
OCF(TTM)-0.52
OCFYN/A
SpS2.32
BVpS4.97
TBVpS4.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.37%
ROE -42.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.47%
FCFM N/A
ROA(3y)-26.48%
ROA(5y)-20.1%
ROE(3y)-31.79%
ROE(5y)-24.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.75%
GM growth 5Y-4.23%
F-Score3
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 22.28%
Cap/Sales 0.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.65
Quick Ratio 7.65
Altman-Z 5.69
F-Score3
WACC11.22%
ROIC/WACCN/A
Cap/Depr(3y)472.89%
Cap/Depr(5y)307.85%
Cap/Sales(3y)12.2%
Cap/Sales(5y)7.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-69.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-640%
EPS Next Y-51.94%
EPS Next 2Y4.49%
EPS Next 3Y29.42%
EPS Next 5Y25.04%
Revenue 1Y (TTM)14.34%
Revenue growth 3Y15.45%
Revenue growth 5Y19.95%
Sales Q2Q%-19.44%
Revenue Next Year10.06%
Revenue Next 2Y12.92%
Revenue Next 3Y16.51%
Revenue Next 5Y34.07%
EBIT growth 1Y-18.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year21.13%
EBIT Next 3Y24.81%
EBIT Next 5YN/A
FCF growth 1Y39.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.92%
OCF growth 3YN/A
OCF growth 5YN/A